Stay updated with breaking news from Fred Schwarzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day, everyone, and welcome to the IGM Biosciences' Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Call. Today's call is being recorded.
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Rating)’s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $25.33, but opened at $25.99. IGM Biosciences shares last traded at $24.67, with a volume of 58 shares changing hands. Wall Street Analyst Weigh In A number of equities research analysts have […]
– Targeted IL-15/IL-15R IgM antibody to be evaluated for safety and pharmacodynamic effects –MOUNTAIN VIEW, Calif., Jan. 17, 2023 -- IGM Biosciences, Inc. , a clinical-stage... | January 17, 2023
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Data from T cell Engager Portfolio for Hematologic Malignancies, Including First... | November 3, 2022
GuruFocus Article or News written by PurpleRose and the topic is about: